Live Breaking News & Updates on Identifying Surrogate Endpoints

Stay updated with breaking news from Identifying surrogate endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

/PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual. ....

United States , United Kingdom , Jonathan Barratt , Garethj Thomas , Gareth Thomas , American Society Of Nephrology Kidney Health Initiative , University Of Leicester , Iga Nephropathy Network , Renal Research Group , Phd University Hospital Southampton , University Of Southampton , Life Sciences , Rare Disease Group , Inderes Event Studio , University Hospital Southampton , Experimental Pathology , United Kingdom National Registry , Rare Kidney Diseases , In Ternational Iga Nephropathy , Chief Investigator , American Society , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Iga Nephropathy Work , Calliditas Therapeutics ,

Calliditas Therapeutics: In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

STOCKHOLM, May 16, 2024 /PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual R&D day ....

United States , United Kingdom , Jonathan Barratt , Garethj Thomas , Gareth Thomas , Phd University Hospital Southampton , Renal Research Group , Life Sciences , University Of Leicester , American Society Of Nephrology Kidney Health Initiative , Iga Nephropathy Network , University Of Southampton , Rare Disease Group , Inderes Event Studio , University Hospital Southampton , Experimental Pathology , United Kingdom National Registry , Rare Kidney Diseases , In Ternational Iga Nephropathy , Chief Investigator , American Society , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Iga Nephropathy Work , Ihr Portfolio ,

Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase ...

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today ....

United Kingdom , Long Island Jewish Medical Center , New York , United States , Jonathan Barratt , Joyce Allaire , Richard Lafayette , Mari Purpura , Stanford University Department Of Medicine , Nephrology At Stanford University , Communications Committee , Stanford Glomerular Disease Center , Renal Research Group , Glomerular Disease Advisory Committee , American Society Of Nephrology , Lotte New York Palace Hotel , Stanford University School Of Medicine , American Society Of Nephrology Kidney Health Initiative , Exchange Commission , University Of Leicester , Vera Therapeutics Inc , College Of Life Sciences , Stanford University Medical Center , York Medical College , Igan Rare Disease Group , Drug Administration ,

Vera Therapeutics Hosting a Key Opinion Leader Webinar on

BRISBANE, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and. ....

United Kingdom , United States , Jonathan Barratt , University Of Leicester , International Igan Network , Renal Research Group , Vera Therapeutics Inc , College Of Life Sciences , American Society Of Nephrology Kidney Health Initiative , Igan Rare Disease Group , Vera Therapeutics , Life Sciences , Disease Group , United Kingdom National Registry , Rare Kidney Diseases , Chief Investigator , American Society , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Nasdaq Vera , Vera Therapeutics ,